France August 5, 2024BENEFIT trial: isatuximab, lenalidomide, and dexamethasone +/- bortezomib in newly diagnosed myeloma
France July 18, 2024BENEFIT trial: isatuximab, lenalidomide, and dexamethasone +/- bortezomib in newly diagnosed myeloma
United Kingdom November 3, 2023Thurrock Council – Health and Wellbeing Overview and Scrutiny Committee, 02/11/2023
